Showing 15,101 - 15,120 results of 100,261 for search '(( 5 wt decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.65s Refine Results
  1. 15101
  2. 15102
  3. 15103
  4. 15104
  5. 15105
  6. 15106
  7. 15107
  8. 15108
  9. 15109
  10. 15110

    The numerical solution of model (1) for infected compartment vs. time with different scenarios of Phase 6 in the First Case: 1<sup><i>st</i></sup> scenario, no lockdown is implemen... by Sara K. Al-Harbi (12418482)

    Published 2022
    “…<p>The numerical solution of model <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0265779#pone.0265779.e002" target="_blank">(1)</a> for infected compartment vs. time with different scenarios of Phase 6 in the First Case: 1<sup><i>st</i></sup> scenario, no lockdown is implemented; 2<sup><i>nd</i></sup> scenario, no lockdown while <i>SD</i> increases; 3<sup><i>rd</i></sup> scenario, lockdown increases; 4<sup><i>th</i></sup> scenario, <i>SD</i> increases; 5<sup><i>th</i></sup> scenario, lockdown decreases; 6<sup><i>th</i></sup> scenario, <i>SD</i> decreases; 7<sup><i>th</i></sup> scenario, lockdown and <i>SD</i> increases; 8<sup><i>th</i></sup> scenario, lockdown decreases and <i>SD</i> increases; 9<sup><i>th</i></sup> scenario, <i>ρ</i> is the same as in Phase 5; 10<sup><i>th</i></sup> scenario, <i>ρ</i> is the same as in Phase 5 while <i>SD</i> increases.…”
  11. 15111
  12. 15112
  13. 15113
  14. 15114

    Supplementary Material for: Severe Pulmonary Hypertension Associated with COPD: Hemodynamic Improvement with Specific Therapy by Girard A. (4154179)

    Published 2015
    “…First-line treatments were endothelin receptor antagonists in 11 patients, phosphodiesterase-5 inhibitors in 11 patients, calcium blocker in 1 patient, combination therapy in 3 patients including 2 with a prostanoid. …”
  15. 15115

    Discovery of indolylpiperazinylpyrimidines with dual-target profiles at adenosine A<sub>2A</sub> and dopamine D<sub>2</sub> receptors for Parkinson's disease treatment - Fig 5 by Yi-Ming Shao (577266)

    Published 2018
    “…<p>Dose-response curves of compound <b>5</b> (A), compound <b>6</b> (B) and (±)-PPHT.HCl (C) in D<sub>2</sub>R-proteopolymersomes-based fluorescence polarisation (FP) competition assay with BODIPY-NAPS. …”
  16. 15116

    Table1_Case Report: Chanarin-Dorfman Syndrome: A Novel Homozygous Mutation in ABHD5 Gene in a Chinese Case and Genotype-Phenotype Correlation Analysis.xlsx by Bo Liang (450389)

    Published 2022
    “…<p>The Chanarin–Dorfman syndrome (CDS) is a rare, autosomal recessively inherited genetic disease, whch is associated with a decrease in the lipolysis activity in multiple tissue cells. …”
  17. 15117

    DataSheet_1_MiR-199a-5P promotes osteogenic differentiation of human stem cells from apical papilla via targeting IFIT2 in apical periodontitis.pdf by Jing Hu (41899)

    Published 2023
    “…RNA binding protein immunoprecipitation (RIP) and Luciferase reporter assay were conducted to identify the target gene of miR-199a-5p.</p>Results<p>The expression of miR-199a-5p was decreased in the periapical tissues of AP patients, and miR-199a-5p mimics markedly enhanced cell proliferation and osteogenic differentiation of hSCAPs, while miR-199a-5p antagomir dramatically attenuated hSCAPs osteogenesis. …”
  18. 15118

    Immunostaining patterns of 5-mC and 5-hmC in normal glandular epithelium and adenocarcinoma in situ (AIS). by Jobran M. Moshi (18405149)

    Published 2024
    “…Note the dramatic decrease in 5-hmC immunofluorescence in the AIS structures (gland 1 normal columnar epithelium, glands 2 and 3 containing AIS structures). …”
  19. 15119
  20. 15120